For decades, the body mass index has served as the medical community's shorthand for assessing weight-related health. Calculated simply from height and weight, BMI categorizes millions as healthy, overweight or obese. But a growing body of research reveals that this ubiquitous measurement overlooks critical differences in body composition and metabolic function. A new study published in Science Bulletin analyzing more than 4.2 million Chinese adults aged 35 to 75 has found that alternative measurements — particularly those assessing visceral fat and metabolic function — provide markedly better predictions for cardiovascular disease, diabetes and other major health conditions. The findings, collected between November 2014 and December 2023 with over 20 million person-years of follow-up, challenge the medical establishment's reliance on a single number to define health risk.
Researchers evaluated 15 distinct obesity and metabolic indices, which were systematically grouped into three categories for comprehensive analysis. The first category encompassed body shape-related measurements, including the commonly used body mass index (BMI), waist-to-height ratio, and a body shape index. The second category focused on visceral fat-related parameters, such as the lipid accumulation product, which estimates dangerous fat stored around the organs. The third category examined metabolic function-related indices, combining blood markers like triglycerides and glucose to assess underlying metabolic health. The investigation tracked hospitalizations and deaths resulting from cardiovascular disease, diabetes, cancer and chronic obstructive pulmonary disease over an approximate five-year period, providing a thorough look at how these measurements predict long-term health outcomes.
The results demonstrated that no single measurement excelled across all conditions. For cardiovascular disease, indices estimating visceral fat — the deep abdominal fat surrounding organs — performed strongest. For diabetes, measurements combining triglycerides and blood sugar proved superior because they reflect insulin resistance. A body shape index performed relatively better for chronic lung disease. Notably, none of the 15 measurements effectively predicted cancer risk.
The AMA's 2023 policy recommending de-emphasis of BMI acknowledged that the metric, originally developed from data on non-Hispanic white men, has perpetuated misclassification across racial and ethnic groups. Black individuals tend to have lower body fat percentages at the same BMI as white individuals, while Asian individuals tend to carry more body fat — and thus greater metabolic risk — at lower BMI thresholds.
The study and supporting research suggest four key measurements provide more accurate health assessments:
The research underscores a fundamental truth about metabolic health: two individuals with identical BMI can have profoundly different risk profiles. One may carry more muscle, while another harbors dangerous visceral fat. One may maintain healthy blood markers while the other shows early signs of metabolic dysfunction. As the American Medical Association and other medical bodies recognize BMI's limitations, the path forward involves replacing a one-size-fits-all approach with comprehensive assessment. Understanding blood pressure, cholesterol and waist measurements alongside body weight provides the complete picture necessary for informed health decisions — a shift from simplifying health to understanding its complexity.
Sources for this article include: